Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > What do you

<< Previous

Bullboard Posts

Next >>

Comment by Actuarialon Feb 09, 2021 3:33pm

255 Views

Post# 32515984

RE:RE:RE:RE:RE:What do you

It is not something gradually - instead, it all happens in a sudden. This will leave all the day traders / penny filippers far behind the train though they could win small but they will eventually miss big.

TriumphSpitSix wrote: I said 15-20% a day yesterday but I'll take $1.00/day as well. I'm not hard to please.

TriumphSpitSix wrote: 15-20% per day for about two weeks should get us there.

YukonJezza wrote:
very far from the predictions I have been reading